Please provide your email address to receive an email when new articles are posted on . Bone marrow aspirate concentrate injections may not provide benefit as an adjuvant for arthroscopic partial ...

Please provide your email address to receive an email when new articles are posted on . Published results showed bone marrow aspirate concentrate yielded positive clinical and functional outcomes for ...

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec, an innovative medical device company specializing in orthopedic and spine technology, is thrilled to announce that it has received 510(k) clearance from ...

CellaVision AB ( ($SE:CEVI) ) has issued an update. CellaVision has achieved CE marking approval for its Bone Marrow Aspirate Application under ...

Bone marrow aspiration and biopsy are cornerstone diagnostic procedures within haematology and oncology, routinely employed to assess disorders ranging from haematological malignancies to metabolic ...

A new study compares the regenerative potential of blood/bone marrow aspirate concentrates obtained from arterial blood, venous blood, and bone marrow aspirate. The study, conducted in rabbits, is ...

The U.S. FDA granted Scopio Labs Ltd. de novo clearance for its artificial intelligence (AI)-powered software which analyzes bone marrow. Scopio’s Full-Field Bone Marrow Aspirate (FF-BMA) system aims ...

Israel-based Scopio Labs announced the FDA granted De Novo clearance for its Full-Field Bone Marrow Aspirate (FF-BMA) software that provides AI-enabled decision support tools for bone marrow analysis.

Today, CellaVision has reached another important milestone and announces that its new CellaVision Bone Marrow Aspirate (BMA) Application has received CE marking approval as a Class C product under the ...

Scopio's CE-Marked Full-Field Bone Marrow Aspirate ™ Application provides an enhanced hematology workflow by utilizing AI and imaging of vast numbers of cells to overcome limitations of manual ...